ITEM METADATA RECORD
Title: Bioluminescence imaging of therapy response does not correlate with FDG-PET response in a mouse model of Burkitt lymphoma
Authors: De Saint-Hubert, Marijke ×
Devos, Ellen
Ibrahimi, Abdelilah
Debyser, Zeger
Mortelmans, Luc
Mottaghy, Felix M #
Issue Date: 2012
Publisher: E-Century Publishing Corporation
Series Title: American Journal of Nuclear Medicine and Molecular Imaging vol:2 issue:3 pages:353-361
Abstract: Since the development and evaluation of novel anti-cancer therapies require molecular insight in the disease state, both FDG-PET and BLI imaging were evaluated in a Burkitt B-cell lymphoma xenograft model treated with cyclophosphamide or temsirolimus. Daudi xenograft mice were treated with either cyclophosphamide or temsirolimus and imaged with BLI and FDG-PET on d0 (before treatment), d2, d4, d7, d9 and d14 following the start of therapy. Besides tumor volume changes, therapy response was assessed with immunohistochemical analysis (apoptosis). BLI revealed a flare following both therapeutics that was significantly higher when compared to control tumors. FDG-PET decreased immediatelly, long before the tumor reduced in size. Late after therapy, BLI signal intensities decreased significantly compared to baseline subsequent to tumor size reduction while apoptosis was immediately induced following both treatment regimen. Unlike FDG, BLI was not able to reflect reduced levels of viable cells and was not able to predict tumor size response and apoptosis response.
ISSN: 2160-8407
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Faculty of Medicine @ Kulak
Molecular Virology and Gene Therapy
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Bioluminescence (2012).pdf Published 1948KbAdobe PDFView/Open

These files are only available to some KU Leuven staff members

 


All items in Lirias are protected by copyright, with all rights reserved.